BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2015
View Archived Issues
Cyclic pyranopterin monophosphate substitution in neonates with molybdenum cofactor deficiency
Read More
Preclinical findings for NanoBio's intranasal nanoemulsion adjuvanted chlamydia vaccine
Read More
Morphotek and University of Wisconsin-Madison to study farletuzumab
Read More
Interim data released from phase II study of KRN-23 for XLH, phase III study enrolls first patient
Read More
Pluristem and Fukushima Medical University sign MOU for collaboration to study PLX-R18 for ARS
Read More
First patient recruited in phase II/III trial of Toca-511/Toca-FC in high-grade glioma
Read More
Coordinated delivery of anticancer drug combinations reduces toxicity
Read More
Texas Biomedical Research Institute receives NIH grant to develop cure for HIV infection in infants
Read More
Stem Cell Medicine, Ramot and Yeda sign license agreement for stem cell treatments
Read More
Intravenous Taigexyn achieves primary endpoint in phase III trial in community-acquired pneumonia
Read More
Fluorescent tracer MB-102 devised for noninvasive glomerular filtration rate measurement
Read More
Novavax initiates phase III trial of RSV F vaccine
Read More
Biotest cleared for phase III evaluation of BT-524 fibrinogen concentrate
Read More
Cytos Biotechnology and Kuros Biosurgery combine to create Kuros Biosciences
Read More
EMA validates Gilead's MAA for fixed-dose sofosbuvir/velpatasvir
Read More
New inhibitors block Ewing's sarcoma cell growth in vitro and in vivo
Read More
Radiation sensitizer NVX-108 receives FDA orphan drug designation
Read More
Calibr discloses integrin alphavbeta6 receptor antagonists
Read More
MUSC Foundation for Research Development patents anticancer agents
Read More
Molecular Targeting Technologies and NHRI develop anticancer drug conjugates
Read More
SpsB inhibitors reported in RQx Pharmaceuticals patent
Read More
Genentech and Roche report retinoid RORgamma ligands
Read More
Sealife Pharma presents antibacterial agents
Read More
Multiple dosing begun in phase I trial of CCX-872-B in pancreatic cancer
Read More
Samsung Bioepis obtains Korean approval for Renflexis and updates pipeline status
Read More
First-in-human data for ASTX-727 in myelodysplastic syndromes presented at ASH
Read More
Eli Lilly to cease development of basal insulin peglispro
Read More
Consortium invests in Athera Biotechnologies to further development of PC-mAB
Read More
First response to a BET inhibitor seen in NUT midline carcinoma
Read More
Zymeworks and GSK enter collaboration and license agreement for Fc-engineered antibodies
Read More